Epileptic Disorders
MENURefractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes Volume 18, numéro 1, March 2016
Auteurs
1 Department of Neurology
2 Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham Hospital, Birmingham, AL, USA
* Correspondence: Ayaz M. Khawaja
University of Alabama at Birmingham Hospital,
1720 7th Avenue South,
Birmingham,
AL, 35233, USA
- Mots-clés : glutamic acid decarboxylase, status epilepticus, refractory seizures, NORSE, RSE, immunotherapy, chemotherapy, anti-GAD antibody
- DOI : 10.1684/epd.2016.0797
- Page(s) : 34-43
- Année de parution : 2016
Aim
Glutamic acid decarboxylase antibodies (GAD-Abs) have been implicated in refractory epilepsy. The association with refractory status epilepticus in adults has been rarely described. We discuss our experience in managing three adult patients who presented with refractory status epilepticus associated with GAD-Abs.